Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.57 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | BAX | Q07812 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10678296 | 0.86 | LTA4H (0.57) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL29110245 | 0.84 | PARP10 (0.55) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL19402993 | 0.82 | PARP10 (0.53) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL8043656 | 0.82 | MMP13 (0.53) | TSHRPARP10SMN1; SMN2 | |
| SCHEMBL26604318 | 0.82 | PARP10 (0.53) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL13567787 | 0.81 | PARP10 (0.48) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL4025301 | 0.81 | MEN1 (0.52) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL28031984 | 0.80 | LTA4H (0.63) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL122719 | 0.79 | LTA4H (0.92) | LTA4HTSHRPARP10NR1H2BAX | |
| SCHEMBL22129853 | 0.79 | LTA4H (0.92) | LTA4HTSHRPARP10NR1H2BAX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021013733-A1 | ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION | ABIVAX (FR) | 2021-01-28 | — | — | WO | disclosed |